Accordingly, it had been shown on this paper that the vessel density in xenografts significantly diminished upon NT combination treatment as compared to controls (Fig. 5), and this might account in part for why nimotuzumab did not enhance TMZ‐induced cytotoxicity in EGFR‐overexpressing glioma cells in vitro. This evidence concerns the gene EGFR and central nervous system cancer.